Xvivo Perfusion: Breakthrough device designation for XHPS
Research Note
2019-12-16
11:48
Xvivo reports that the company has been granted breakthrough device designation (BDD) from the US FDA for the XVIVO Heart Preservation System (XHPS). We have adjusted our fair value accordingly.
AN
Arvid Necander
Disclosures and disclaimers